Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission

A double dissociation in the effects of 5-HT2A and 5-HT2C receptors on the acquisition and expression of conditioned defeat in Syrian hamsters.

(2012) Marquinta L. Harvey et al.   BEHAVIORAL NEUROSCIENCE

Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons

(2012) Dipesh Chaudhury et al.   NATURE

Glutamate Neurocircuitry: Theoretical Underpinnings in Schizophrenia

(2012) Thomas L. Schwartz et al.   Frontiers in Pharmacology

Cariprazine (RGH-188), a potent D3/D2 dopamine receptor partial agonist, binds to dopamine D3 receptors in vivo and shows antipsychotic-like and procognitive effects in rodents

(2011) István Gyertyán et al.   NEUROCHEMISTRY INTERNATIONAL

From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment

(2011) Bita Moghaddam et al.   NEUROPSYCHOPHARMACOLOGY

Pimavanserin tartrate, a 5-HT2A receptor inverse agonist, increases slow wave sleep as measured by polysomnography in healthy adult volunteers

(2011) Sonia Ancoli-Israel et al.   SLEEP MEDICINE

Targeting glutamate synapses in schizophrenia

(2011) Julie R. Field et al.   TRENDS IN MOLECULAR MEDICINE

Nerve agent exposure elicits site-specific changes in protein phosphorylation in mouse brain

(2010) Hongwen Zhu et al.   BRAIN RESEARCH

Effects of asenapine on prefrontal N-methyl-D-aspartate receptor-mediated transmission: Involvement of dopamine D1 receptors

(2010) Kent Jardemark et al.   SYNAPSE

Pharmacological validation of a chronic social stress model of depression in rats: effects of reboxetine, haloperidol and diazepam

(2009) Rafal Rygula et al.   BEHAVIOURAL PHARMACOLOGY

WS-50030 [7- -1,3-benzoxazol-2(3H)-one]: A Novel Dopamine D2 Receptor Partial Agonist/Serotonin Reuptake Inhibitor with Preclinical Antipsychotic-Like and Antidepressant-Like Activity

(2009) J. A. Brennan et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Metabolic side effects of antipsychotic drug treatment – pharmacological mechanisms

(2009) Gavin P Reynolds et al.   PHARMACOLOGY & THERAPEUTICS

Metabolic profiles of second-generation antipsychotics in early psychosis: Findings from the CAFE study

(2009) Jayendra K. Patel et al.   SCHIZOPHRENIA RESEARCH

Akt/GSK3 Signaling in the Action of Psychotropic Drugs

(2008) Jean-Martin Beaulieu et al.   Annual Review of Pharmacology and Toxicology

Phospho-regulation of synaptic and extrasynaptic N-methyl-d-aspartate receptors in adult hippocampal slices

(2008) S.M. Goebel-Goody et al.   NEUROSCIENCE